Explore how cancer research is advancing and how it’s transforming the pharma and biotech sectors in the process.
The increased investment in cancer has brought a new era of treatments to the forefront including cell and gene therapies, antibody drug conjugates, checkpoint inhibitors and more. Looking ahead, the industry still has to overcome key hurdles in order to continue expanding access and improving outcomes.
Included in this trendline:
- How leading oncology drugmakers set the stage for future advances
- With ADCs on the rise, drugmakers embrace a new oncology pillar
- AbbVie’s ADC win shows how pharma can break through in solid tumors
Offered Free by: PharmaVoice and Quest Diagnostics
See All Resources from: PharmaVoice and Quest Diagnostics
